Gene therapy, also called as human gene transfer is an experimental therapy which uses corrective genes to treat genetic diseases/disorders such as cystic fibrosis and muscular dystrophy. There are two types of gene therapy depending on which cell types are being treated namely, Somatic gene therapy and Germline gene therapy.

The global gene therapy market report has been segmented on the basis of vector type, gene type, application, and region.

On the basis of vector type, the global gene therapy market has been segmented into viral vector and non-viral vector. The viral vector segment is further sub-segmented into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, and vaccinia virus. The non-viral vector segment is further sub-segmented into naked/plasmid vectors, gene gun, electroporation, and lipofection. The viral vector segment is projected to account for highest share in terms of revenue in the global market during the forecast period.

On the basis of application segments, the global gene therapy market has been segmented into oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. The viral oncological disorders segment is expected to account for highest share in the global gene therapy market in terms of revenue. The cardiovascular diseases segment is projected to witness highest CAGR over the forecast period.

Do Inquiry of the Report Here: https://marketresearch.biz/report/gene-therapy-market/#inquiry

On the basis of region, the global gene therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market accounted for largest market share in the global gene therapy market in 2016, and is estimated to maintain its dominance over the forecast period. Asia Pacific gene therapy market is expected to witness high growth during the next ten years.

Key players operating in the global gene therapy market include Epeius Biotechnologies, Amgen, Abeona Therapeutics, Juno Therapeutics, Sanofi, UniQure, Celgene, Adaptimmune, and Advantagene.